A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
11/2009
11/24/2009	CA2423930C Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid
11/24/2009	CA2421504C 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors
11/24/2009	CA2419877C Storage stable tretinoin and 4-hydroxy anisole containing topical composition
11/24/2009	CA2385882C Tyrosine derivatives
11/24/2009	CA2376870C Method for scavenging radicals with urocanic acid, derivatives and analogues
11/24/2009	CA2341566C Use of lithium gluconate for making a medicine for treating herpes and seborrheic dermatitis
11/24/2009	CA2264647C Fragmented polymeric hydrogels for adhesion prevention and their preparation
11/24/2009	CA2201105C Inhibitor of stem cell proliferation and uses thereof
11/22/2009	CA2666400A1 Composition and method of treating facial skin defect
11/19/2009	WO2009139373A1 Amide compound
11/19/2009	WO2009139361A1 Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative having substituted oxy group
11/19/2009	WO2009139231A1 Extract produced from orchid family plant, method for production thereof, and preparation for external application to skin comprising extract produced from orchid family plant
11/19/2009	WO2009138978A2 Compositions for topical application comprising microencapsulated colorants
11/19/2009	WO2009138517A1 Emollient composition
11/19/2009	WO2009138516A1 Therapy regimen for treating acne related diseases
11/19/2009	WO2009138515A1 Emollient composition for the preventive treatment of atopic dermatitis
11/19/2009	WO2009138487A1 Pharmaceutical compositions for the treatment of warts
11/19/2009	WO2009137880A1 Use of angiogenin or angiogenin agonists for treating diseases and disorders
11/19/2009	WO2009137879A1 Orally administrable dosage forms comprising angiogenin and uses thereof
11/19/2009	WO2009123457A3 Ubiquitin alone or in combination for use in the treatment of sweet itch
11/19/2009	WO2009116524A9 Modified protein
11/19/2009	WO2009103427A3 Use of 3-(4-hydroxy-3-methoxyphenyl)-1(4-hydroxyphenyl)-propane-1-on against hyperpigmentation
11/19/2009	WO2009098320A3 Macrolides for treating diseases mediated through pde inhibition
11/19/2009	WO2009007411A3 Inhibition of age formation
11/19/2009	US20090286986 Isoindole-imide compounds, compositions, and uses thereof
11/19/2009	US20090286874 Anti-aging composition containing phloretin
11/19/2009	US20090286871 Use of a plant oil product as an agent for increasing the synthesis of skin lipids
11/19/2009	US20090286858 Assays for modulators of asparaginyl hydroxylase
11/19/2009	US20090286849 Modulation of insulin like growth factor i receptor expression
11/19/2009	US20090286822 Treatment of psoriasis and of other skin disorders associated with inhibition of differentiation of epidermal cells
11/19/2009	US20090286787 Substituted gamma lactams as therapeutic agents
11/19/2009	US20090286786 Compounds having a 4-pyridylalkylthio group as a substituent
11/19/2009	US20090286780 2-oxochromene derivatives
11/19/2009	US20090286769 Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
11/19/2009	US20090286742 polypeptides comprising amino acid sequences corresponding to, similar to or homologous to part of the amino acid sequence of neural thread proteins, used for treating unwanted cellular proliferations such as benign prostatatic hyperplasia, cancer, unwanted facial hair, warts and fatty tissues
11/19/2009	US20090286736 using polypeptide comprising a membrane translocation domain and a NF- kappa B Essential Modulator (NEMO) binding sequence; comprising a NEMO binding domain (NBD)
11/19/2009	US20090286734 Pharmaceutical Use of Alpha Antigen or Alpha Antigen Gene
11/19/2009	US20090286729 Epidermal Growth Factor Receptor Antagonists and Methods of Use
11/19/2009	US20090285917 Composition comprising complex crude drug extracts showing anti-allergic rhinitis, anti-atopic dermatitis and anti-asthma activity
11/19/2009	US20090285906 Preparation Made From Diptera Larvae For The Treatment Of Wounds
11/19/2009	US20090285850 Oral Carotenoid Supplementation Methods for Improving the Health and Appearance of Skin
11/19/2009	US20090285822 Prevention and treatment of amyloidogenic disease
11/19/2009	US20090285816 Albumin Fusion Proteins
11/19/2009	US20090285809 Prevention and treatment of amyloidogenic diseases
11/19/2009	US20090285777 Uses of Mammalian Cytokine; Related Reagents
11/19/2009	US20090285775 Treatment of wounds using il-17b
11/19/2009	US20090285770 Topical Compositions for Promoting Homeostasis of the Skin
11/19/2009	US20090285753 Novel haptotactic peptides
11/19/2009	CA2724804A1 Therapy regimen for treating acne related diseases
11/19/2009	CA2724522A1 Emollient composition
11/19/2009	CA2724434A1 Emollient composition for the preventive treatment of atopic dermatitis
11/19/2009	CA2724077A1 Amide compound
11/19/2009	CA2724055A1 Glucocorticoid receptor agonist comprising 2,2,4-trimethyl-6-phenyl-1,2 -dihydroquinoline derivatives having substituted oxy group
11/19/2009	CA2724048A1 Oral preparation
11/19/2009	CA2723987A1 Use of angiogenin or angiogenin agonists for treating diseases and disorders
11/19/2009	CA2723834A1 Pharmaceutical compositions for the treatment of warts
11/18/2009	EP2119718A1 Macrocyclic compound
11/18/2009	EP2119475A1 Composition containing the combination of 2,4 diaminopyrimidine-3-n-oxide and of madecassoside and/or of terminoloside; use of the combination for inducing and/or stimulating the growth of human keratin fibres and/or preventing their loss.
11/18/2009	EP2119435A1 Emollient composition
11/18/2009	EP2119431A1 Composition containing the combination of madecassoside and/or of terminoloside and of an arginine and/or a salt thereof and/or a derivative thereof; use of the combination for inducing and/or stimulating the growth of human keratin fibres and/or preventing their loss
11/18/2009	EP2117652A1 Cosmetic compositions
11/18/2009	EP2117581A1 Wnt3a for inhibition of scarring
11/18/2009	EP2117565A2 Use of chitosans for the treatment of nail inflammatory diseases
11/18/2009	EP2117536A2 Cosmetic and pharmaceutical applications of n-acylated amino acids and structurally related compounds
11/18/2009	EP2117499A1 Use of derivatives of sinapinic acid and compositions comprising such derivatives
11/18/2009	EP1572148B1 Cosmetic composition comprising a siegesbeckia extract and a lipopeptide
11/18/2009	EP1490064B1 Substituted pyridinones as modulators of p38 map kinase
11/18/2009	EP1238652B1 Cosmetic method for peeling of the skin
11/18/2009	EP0892789B2 Irreversible inhibitors of tyrosine kinases
11/18/2009	EP0760811B1 Imidazole derivatives as histamine receptor h3 modulators
11/18/2009	CN101583598A Novel indole derivative having inhibitory activity on i kappa b kinase ss
11/18/2009	CN101583377A Treatment of fibrosis
11/18/2009	CN101579485A Bamboo juice skin toning agent
11/18/2009	CN101579475A Traditional Chinese medicine for treating eczema
11/18/2009	CN101579470A Oral medicine for treating dermatosis and preparation method thereof
11/18/2009	CN101579448A Traditional Chinese medicine oil for curing burns, scalds and scorches
11/18/2009	CN101579429A Medicament for treating bromhidrosis
11/18/2009	CN101579426A Medicine for treating tinea manus and pedis
11/18/2009	CN101579423A Medicament composition for treating beriberi and preparation method thereof
11/18/2009	CN101579420A External medicine for curing lepriasis old ulcerative-point erosion as well as burns and scalds
11/18/2009	CN101579401A Ointment for external use for treating burns and scalds
11/18/2009	CN101579307A Application of hypertonic injection to preparation of medicament accelerating wound healing
11/18/2009	CN100560589C Imidazoselenazole compounds and their use for prevention and/or treatment of diseases relative to protein aging
11/18/2009	CN100560129C Use of inhibitors of enzymes with APN and/or DPIV activity for the treatment of dermatological diseases involving the hyperproliferation and modified differentiation conditions of fibroblasts
11/18/2009	CN100560128C Repairing paste of emu oil and its production
11/18/2009	CN100560126C Orally-administered Chinese medicine for treating acne and preparation thereof
11/18/2009	CN100560110C Chinese-medicinal compound preparation for treating injury
11/18/2009	CN100560100C Bedsore treatment liquid with centipede and preparation method thereof
11/18/2009	CN100560084C Method and preparations having effect against allergic symptoms
11/18/2009	CN100560057C Wound-protection liquid, and its preparing method
11/18/2009	CN100560056C Compound all-trans retinoic acid cream and its preparation method and application
11/18/2009	CN100560051C Composition for promoting hair growth
11/18/2009	CN100560050C Use of total cistanchis glycoside for inhibiting skin pigment deposition and whitening
11/17/2009	US7619100 Physiologically active substances
11/17/2009	US7619001 Utilization of dialkylfumarates
11/17/2009	US7618977 Method of treating dermatitis comprising administering a chymase inhibitor
11/17/2009	US7618643 Growth factor delivery system for the healing of wounds and the prevention of inflammation and disease
11/17/2009	US7618638 Matrix metalloprotease inhibitor
11/17/2009	US7618629 Manipulation of cytokine levels using CD83 gene products
11/17/2009	US7618621 Preparing culture of pluripotent brain tissue for nervous tissue regeneration, tissue engineering and treating nervous system disorders

1 ... 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 ... 1065